fbpx
QQQ
+ 2.16
342.20
+ 0.63%
DIA
+ 0.25
338.53
+ 0.07%
SPY
+ 1.44
419.43
+ 0.34%
TLT
+ 0.02
143.27
+ 0.01%
GLD
-0.50
167.45
-0.3%

10 Biggest Price Target Changes For Thursday

May 28, 2020 8:22 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
  • KeyBanc boosted Autodesk, Inc. (NASDAQ:ADSK) price target from $210 to $223. Autodesk closed at $199.81 on Wednesday.
  • Canaccord Genuity boosted HEICO Corporation (NYSE:HEI) price target from $90 to $100. HEICO closed at $105.15 on Wednesday.
  • Raymond James boosted the price target for Polaris Inc. (NYSE:PII) from $81 to $108. Polaris closed at $90.89 on Wednesday.
  • JMP Securities cut the price target for Nutanix, Inc. (NASDAQ:NTNX) from $52 to $45. Nutanix shares closed at $24.91 on Wednesday.
  • Mizuho boosted the price target on Workday, Inc. (NASDAQ:WDAY) from $175 to $220. Workday shares closed at $170.38 on Wednesday.
  • HC Wainwright & Co. raised the price target for Mesoblast Limited (NASDAQ:MESO) from $14 to $21. Mesoblast closed at $13.20 on Wednesday.
  • Needham lifted the price target for Semtech Corporation (NASDAQ:SMTC) from $47 to $65. Semtech shares closed at $50.21 on Wednesday.
  • SVB Leerink boosted the price target for Abiomed, Inc. (NASDAQ:ABMD) from $195 to $225. Abiomed closed at $207.76 on Wednesday.
  • Piper Sandler lifted the price target on BlackLine, Inc. (NASDAQ:BL) from $69 to $78. BlackLine closed at $69.90 on Wednesday.
  • Morgan Stanley raised BeiGene, Ltd. (NASDAQ:BGNE) price target from $184 to $190. BeiGene shares closed at $160.91 on Wednesday.

 

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

10 Biggest Price Target Changes For Monday

Morgan Stanley lowered the price target for American Express Company (NYSE: AXP) from $117 to $113. American Express closed at $83.17 on Friday. read more

10 Biggest Price Target Changes For Friday

Deutsche Bank Initiates Coverage On Abiomed with Buy Rating, Announces Price Target of $360

Deutsche Bank analyst Pito Chickering initiates coverage on Abiomed (NASDAQ:ABMD) with a Buy rating and announces Price Target of $360. read more

Morgan Stanley Maintains Underweight on Abiomed, Raises Price Target to $245

Morgan Stanley maintains Abiomed (NASDAQ:ABMD) with a Underweight and raises the price target from $238 to $245. read more